comprehensive -WSS

comprehensive

author：focus 2025-10-01 15:28:55 - browse：62776

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： 5 ways to address the shortage of health care workers

focus

WSS

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Doctor of U.S. President Joe Biden says he is fit for duty

The most pressing bird flu mysteries scientists want answered

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Take antibiotics after sex, CDC recommends for certain risk groups

Elisabeth Bik tackles the widespread issue of research misconduct

focus

comprehensive

focus

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Apple is now the first public company to be valued at $3 trillion

Neuroscience renaissance leads to new crop of psychiatric drugs

At least 13 dead in Texas as scorching temps continue

Elevance PBM president out as customers face prescription chaos

After affirmative action ruling, medical educators look to 'holistic review'

Redefining sustainability for the pharmaceutical industry

Cancer drug shortages should be causing more outrage

Doctor of U.S. President Joe Biden says he is fit for duty

hotspot

Virtual repurposing can help discover new uses for existing drugs

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

FDA approves Moderna’s RSV vaccine, its second licensed product

UnitedHealth CEO's Medicaid comments send insurer stocks diving

FDA approves Moderna’s RSV vaccine, its second licensed product

Laying a path for careers in science

Wikipedia

leisure time

focus

Wikipedia